APO Research
Talk to an analyst

APO RESEARCH · REPORT

Viibryd (Vilazodone)

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Viibryd (Vilazodone) Industry Growth and Trends Forecast to 2032

22 December 202579 pages

Choose your research edition.

Industry ResearchViibryd (Vilazodone) Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Viibryd (Vilazodone) Industry Growth and Trends Forecast to 203279 pages · $3,450 USDMarket StructureGlobal Viibryd (Vilazodone) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Viibryd (Vilazodone) Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Viibryd (Vilazodone) Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Viibryd (Vilazodone) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Viibryd (Vilazodone) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Viibryd (Vilazodone) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Viibryd (Vilazodone) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Viibryd (Vilazodone) include Clinical Data, Inc., Allergan plc (AbbVie Inc.) and Actavis Generics (Teva), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Viibryd (Vilazodone) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Viibryd (Vilazodone) market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Viibryd (Vilazodone) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Viibryd (Vilazodone).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Viibryd (Vilazodone) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Viibryd (Vilazodone) Market by Company

Clinical Data, Inc.

Allergan plc (AbbVie Inc.)

Actavis Generics (Teva)

Viibryd (Vilazodone) Segment by Type

10 mg

20 mg

40 mg

Viibryd (Vilazodone) Segment by Application

Major Depression

Anxiety

Others

Viibryd (Vilazodone) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Viibryd (Vilazodone) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Viibryd (Vilazodone) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Viibryd (Vilazodone).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Viibryd (Vilazodone) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Viibryd (Vilazodone) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 10 mg Table 2. Major Company of 20 mg Table 3. Major Company of 40 mg Table 4. Global Viibryd (Vilazodone) Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Viibryd (Vilazodone) Sales by Type (2021-2026) & (k units) Table 6. Global Viibryd (Vilazodone) Sales Market Share in Volume by Type (2021-2026) Table 7. Global Viibryd (Vilazodone) Sales by Type (2021-2026) & (US$ Million) Table 8. Global Viibryd (Vilazodone) Sales Market Share in Value by Type (2021-2026) Table 9. Global Viibryd (Vilazodone) Price by Type (2021-2026) & (US$/unit) Table 10. Global Viibryd (Vilazodone) Sales by Type (2027-2032) & (k units) Table 11. Global Viibryd (Vilazodone) Sales Market Share in Volume by Type (2027-2032) Table 12. Global Viibryd (Vilazodone) Sales by Type (2027-2032) & (US$ Million) Table 13. Global Viibryd (Vilazodone) Sales Market Share in Value by Type (2027-2032) Table 14. Global Viibryd (Vilazodone) Price by Type (2027-2032) & (US$/unit) Table 15. North America Viibryd (Vilazodone) Sales by Type (2021-2026) & (k units) Table 16. North America Viibryd (Vilazodone) Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Viibryd (Vilazodone) Sales by Type (2021-2026) & (k units) Table 18. Europe Viibryd (Vilazodone) Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Viibryd (Vilazodone) Sales by Type (2021-2026) & (k units) Table 20. Asia-Pacific Viibryd (Vilazodone) Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Viibryd (Vilazodone) Sales by Type (2021-2026) & (k units) Table 22. Latin America Viibryd (Vilazodone) Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Viibryd (Vilazodone) Sales by Type (2021-2026) & (k units) Table 24. Middle East and Africa Viibryd (Vilazodone) Sales by Type (2021-2026) & (US$ Million) Table 25. Viibryd (Vilazodone) Industry Trends Table 26. Viibryd (Vilazodone) Industry Drivers Table 27. Viibryd (Vilazodone) Industry Opportunities and Challenges Table 28. Viibryd (Vilazodone) Industry Restraints Table 29. Global Viibryd (Vilazodone) Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Viibryd (Vilazodone) Revenue Market Share by Company (2021-2026) Table 31. Global Viibryd (Vilazodone) Sales by Company (2021-2026) & (k units) Table 32. Global Viibryd (Vilazodone) Sales Share by Company (2021-2026) Table 33. Global Viibryd (Vilazodone) Market Price by Company (2021-2026) & (US$/unit) Table 34. Global Viibryd (Vilazodone) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Viibryd (Vilazodone) Major Company Production Sites and Headquarters Table 36. Global Viibryd (Vilazodone) Company, Product Type & Application Table 37. Global Viibryd (Vilazodone) Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Viibryd (Vilazodone) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Viibryd (Vilazodone) Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Viibryd (Vilazodone) Sales by Region (2021-2026) & (k units) Table 42. Global Viibryd (Vilazodone) Sales Market Share in Volume by Region (2021-2026) Table 43. Global Viibryd (Vilazodone) Sales by Region (2021-2026) & (US$ Million) Table 44. Global Viibryd (Vilazodone) Sales Market Share in Value by Region (2021-2026) Table 45. Global Viibryd (Vilazodone) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Global Viibryd (Vilazodone) Sales by Region (2027-2032) & (k units) Table 47. Global Viibryd (Vilazodone) Sales Market Share in Volume by Region (2027-2032) Table 48. Global Viibryd (Vilazodone) Sales by Region (2027-2032) & (US$ Million) Table 49. Global Viibryd (Vilazodone) Sales Market Share in Value by Region (2027-2032) Table 50. Global Viibryd (Vilazodone) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 51. Global Viibryd (Vilazodone) Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Viibryd (Vilazodone) Sales by Application (2021-2026) & (k units) Table 53. Global Viibryd (Vilazodone) Sales Market Share in Volume by Application (2021-2026) Table 54. Global Viibryd (Vilazodone) Sales by Application (2021-2026) & (US$ Million) Table 55. Global Viibryd (Vilazodone) Sales Market Share in Value by Application (2021-2026) Table 56. Global Viibryd (Vilazodone) Price by Application (2021-2026) & (US$/unit) Table 57. Global Viibryd (Vilazodone) Sales by Application (2027-2032) & (k units) Table 58. Global Viibryd (Vilazodone) Sales Market Share in Volume by Application (2027-2032) Table 59. Global Viibryd (Vilazodone) Sales by Application (2027-2032) & (US$ Million) Table 60. Global Viibryd (Vilazodone) Sales Market Share in Value by Application (2027-2032) Table 61. Global Viibryd (Vilazodone) Price by Application (2027-2032) & (US$/unit) Table 62. North America Viibryd (Vilazodone) Sales by Application (2021-2026) & (k units) Table 63. North America Viibryd (Vilazodone) Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Viibryd (Vilazodone) Sales by Application (2021-2026) & (k units) Table 65. Europe Viibryd (Vilazodone) Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Viibryd (Vilazodone) Sales by Application (2021-2026) & (k units) Table 67. Asia-Pacific Viibryd (Vilazodone) Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Viibryd (Vilazodone) Sales by Application (2021-2026) & (k units) Table 69. Latin America Viibryd (Vilazodone) Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Viibryd (Vilazodone) Sales by Application (2021-2026) & (k units) Table 71. Middle East and Africa Viibryd (Vilazodone) Sales by Application (2021-2026) & (US$ Million) Table 72. Clinical Data, Inc. Company Information Table 73. Clinical Data, Inc. Business Overview Table 74. Clinical Data, Inc. Viibryd (Vilazodone) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Clinical Data, Inc. Viibryd (Vilazodone) Product Portfolio Table 76. Clinical Data, Inc. Recent Development Table 77. Allergan plc (AbbVie Inc.) Company Information Table 78. Allergan plc (AbbVie Inc.) Business Overview Table 79. Allergan plc (AbbVie Inc.) Viibryd (Vilazodone) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Allergan plc (AbbVie Inc.) Viibryd (Vilazodone) Product Portfolio Table 81. Allergan plc (AbbVie Inc.) Recent Development Table 82. Actavis Generics (Teva) Company Information Table 83. Actavis Generics (Teva) Business Overview Table 84. Actavis Generics (Teva) Viibryd (Vilazodone) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Actavis Generics (Teva) Viibryd (Vilazodone) Product Portfolio Table 86. Actavis Generics (Teva) Recent Development Table 87. North America Viibryd (Vilazodone) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 88. North America Viibryd (Vilazodone) Sales by Country (2021-2026) & (k units) Table 89. North America Viibryd (Vilazodone) Sales Market Share by Country (2021-2026) Table 90. North America Viibryd (Vilazodone) Sales Forecast by Country (2027-2032) & (k units) Table 91. North America Viibryd (Vilazodone) Sales Market Share Forecast by Country (2027-2032) Table 92. North America Viibryd (Vilazodone) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 93. North America Viibryd (Vilazodone) Market Size by Country (2021-2026) & (US$ Million) Table 94. North America Viibryd (Vilazodone) Market Share by Country (2021-2026) Table 95. North America Viibryd (Vilazodone) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 96. North America Viibryd (Vilazodone) Market Share Forecast by Country (2027-2032) Table 97. Europe Viibryd (Vilazodone) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 98. Europe Viibryd (Vilazodone) Sales by Country (2021-2026) & (k units) Table 99. Europe Viibryd (Vilazodone) Sales Market Share by Country (2021-2026) Table 100. Europe Viibryd (Vilazodone) Sales Forecast by Country (2027-2032) & (k units) Table 101. Europe Viibryd (Vilazodone) Sales Market Share Forecast by Country (2027-2032) Table 102. Europe Viibryd (Vilazodone) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 103. Europe Viibryd (Vilazodone) Market Size by Country (2021-2026) & (US$ Million) Table 104. Europe Viibryd (Vilazodone) Market Share by Country (2021-2026) Table 105. Europe Viibryd (Vilazodone) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 106. Europe Viibryd (Vilazodone) Market Share Forecast by Country (2027-2032) Table 107. Asia-Pacific Viibryd (Vilazodone) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 108. Asia-Pacific Viibryd (Vilazodone) Sales by Country (2021-2026) & (k units) Table 109. Asia-Pacific Viibryd (Vilazodone) Sales Market Share by Country (2021-2026) Table 110. Asia-Pacific Viibryd (Vilazodone) Sales Forecast by Country (2027-2032) & (k units) Table 111. Asia-Pacific Viibryd (Vilazodone) Sales Market Share Forecast by Country (2027-2032) Table 112. Asia-Pacific Viibryd (Vilazodone) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 113. Asia-Pacific Viibryd (Vilazodone) Market Size by Country (2021-2026) & (US$ Million) Table 114. Asia-Pacific Viibryd (Vilazodone) Market Share by Country (2021-2026) Table 115. Asia-Pacific Viibryd (Vilazodone) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 116. Asia-Pacific Viibryd (Vilazodone) Market Share Forecast by Country (2027-2032) Table 117. Latin America Viibryd (Vilazodone) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 118. Latin America Viibryd (Vilazodone) Sales by Country (2021-2026) & (k units) Table 119. Latin America Viibryd (Vilazodone) Sales Market Share by Country (2021-2026) Table 120. Latin America Viibryd (Vilazodone) Sales Forecast by Country (2027-2032) & (k units) Table 121. Latin America Viibryd (Vilazodone) Sales Market Share Forecast by Country (2027-2032) Table 122. Latin America Viibryd (Vilazodone) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. Latin America Viibryd (Vilazodone) Market Size by Country (2021-2026) & (US$ Million) Table 124. Latin America Viibryd (Vilazodone) Market Share by Country (2021-2026) Table 125. Latin America Viibryd (Vilazodone) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. Latin America Viibryd (Vilazodone) Market Share Forecast by Country (2027-2032) Table 127. Middle East and Africa Viibryd (Vilazodone) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 128. Middle East and Africa Viibryd (Vilazodone) Sales by Country (2021-2026) & (k units) Table 129. Middle East and Africa Viibryd (Vilazodone) Sales Market Share by Country (2021-2026) Table 130. Middle East and Africa Viibryd (Vilazodone) Sales Forecast by Country (2027-2032) & (k units) Table 131. Middle East and Africa Viibryd (Vilazodone) Sales Market Share Forecast by Country (2027-2032) Table 132. Middle East and Africa Viibryd (Vilazodone) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Middle East and Africa Viibryd (Vilazodone) Market Size by Country (2021-2026) & (US$ Million) Table 134. Middle East and Africa Viibryd (Vilazodone) Market Share by Country (2021-2026) Table 135. Middle East and Africa Viibryd (Vilazodone) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Middle East and Africa Viibryd (Vilazodone) Market Share Forecast by Country (2027-2032) Table 137. Key Raw Materials Table 138. Raw Materials Key Suppliers Table 139. Viibryd (Vilazodone) Distributors List Table 140. Viibryd (Vilazodone) Customers List Table 141. Research Programs/Design for This Report Table 142. Authors List of This Report Table 143. Secondary Sources Table 144. Primary Sources List of Figures Figure 1. Viibryd (Vilazodone) Image Figure 2. Global Viibryd (Vilazodone) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Viibryd (Vilazodone) Market Size (2021-2032) & (US$ Million) Figure 4. Global Viibryd (Vilazodone) Sales (2021-2032) & (k units) Figure 5. 10 mg Image Figure 6. Global 10 mg Sales YoY Growth (2021-2032) & (k units) Figure 7. 20 mg Image Figure 8. Global 20 mg Sales YoY Growth (2021-2032) & (k units) Figure 9. 40 mg Image Figure 10. Global 40 mg Sales YoY Growth (2021-2032) & (k units) Figure 11. Global Viibryd (Vilazodone) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Viibryd (Vilazodone) Market Share by Type 2025 VS 2032 Figure 13. North America Viibryd (Vilazodone) Sales Market Share in Volume by Type in 2025 Figure 14. North America Viibryd (Vilazodone) Sales Market Share in Value by Type in 2025 Figure 15. Europe Viibryd (Vilazodone) Sales Market Share in Volume by Type in 2025 Figure 16. Europe Viibryd (Vilazodone) Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Viibryd (Vilazodone) Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Viibryd (Vilazodone) Sales Market Share in Value by Type in 2025 Figure 19. Latin America Viibryd (Vilazodone) Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Viibryd (Vilazodone) Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Viibryd (Vilazodone) Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Viibryd (Vilazodone) Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Viibryd (Vilazodone) Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Major Depression Image Figure 26. Global Major Depression Sales YoY Growth (2021-2032) & (k units) Figure 27. Anxiety Image Figure 28. Global Anxiety Sales YoY Growth (2021-2032) & (k units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 31. Global Viibryd (Vilazodone) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Viibryd (Vilazodone) Market Share by Application 2025 VS 2032 Figure 33. North America Viibryd (Vilazodone) Sales Market Share in Volume by Application in 2025 Figure 34. North America Viibryd (Vilazodone) Sales Market Share in Value by Application in 2025 Figure 35. Europe Viibryd (Vilazodone) Sales Market Share in Volume by Application in 2025 Figure 36. Europe Viibryd (Vilazodone) Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Viibryd (Vilazodone) Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Viibryd (Vilazodone) Sales Market Share in Value by Application in 2025 Figure 39. Latin America Viibryd (Vilazodone) Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Viibryd (Vilazodone) Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Viibryd (Vilazodone) Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Viibryd (Vilazodone) Sales Market Share in Value by Application in 2025 Figure 43. North America Viibryd (Vilazodone) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. North America Viibryd (Vilazodone) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Viibryd (Vilazodone) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Viibryd (Vilazodone) Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Viibryd (Vilazodone) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Europe Viibryd (Vilazodone) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Viibryd (Vilazodone) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Viibryd (Vilazodone) Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Viibryd (Vilazodone) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Asia-Pacific Viibryd (Vilazodone) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Viibryd (Vilazodone) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Viibryd (Vilazodone) Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Viibryd (Vilazodone) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Latin America Viibryd (Vilazodone) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Viibryd (Vilazodone) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Viibryd (Vilazodone) Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Viibryd (Vilazodone) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Middle East and Africa Viibryd (Vilazodone) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Viibryd (Vilazodone) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Viibryd (Vilazodone) Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Viibryd (Vilazodone) Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Viibryd (Vilazodone) Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 10 mg
  • 20 mg
  • 40 mg
Applications
  • Major Depression
  • Anxiety
  • Others
Companies covered
  • Clinical Data, Inc.
  • Allergan plc (AbbVie Inc.)
  • Actavis Generics (Teva)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Viibryd (Vilazodone) Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Viibryd (Vilazodone) Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Viibryd (Vilazodone) Market by Type
  6. 1.3.1 10 mg
  7. 1.3.2 20 mg
  8. 1.3.3 40 mg
  9. 1.4 Global Viibryd (Vilazodone) Market Size by Type
  10. 1.4.1 Global Viibryd (Vilazodone) Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Viibryd (Vilazodone) Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Viibryd (Vilazodone) Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Viibryd (Vilazodone) Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Viibryd (Vilazodone) Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Viibryd (Vilazodone) Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Viibryd (Vilazodone) Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Viibryd (Vilazodone) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Viibryd (Vilazodone) Industry Trends
  2. 2.2 Viibryd (Vilazodone) Industry Drivers
  3. 2.3 Viibryd (Vilazodone) Industry Opportunities and Challenges
  4. 2.4 Viibryd (Vilazodone) Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Viibryd (Vilazodone) Revenue (2021-2026)
  2. 3.2 Global Top Players by Viibryd (Vilazodone) Sales (2021-2026)
  3. 3.3 Global Top Players by Viibryd (Vilazodone) Price (2021-2026)
  4. 3.4 Global Viibryd (Vilazodone) Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Viibryd (Vilazodone) Major Company Production Sites & Headquarters
  6. 3.6 Global Viibryd (Vilazodone) Company, Product Type & Application
  7. 3.7 Global Viibryd (Vilazodone) Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Viibryd (Vilazodone) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Viibryd (Vilazodone) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Viibryd (Vilazodone) Tier 1, Tier 2, and Tier 3
4 Viibryd (Vilazodone) Regional Status and Outlook
  1. 4.1 Global Viibryd (Vilazodone) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Viibryd (Vilazodone) Historic Market Size by Region
  3. 4.2.1 Global Viibryd (Vilazodone) Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Viibryd (Vilazodone) Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Viibryd (Vilazodone) Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Viibryd (Vilazodone) Forecasted Market Size by Region
  7. 4.3.1 Global Viibryd (Vilazodone) Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Viibryd (Vilazodone) Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Viibryd (Vilazodone) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Viibryd (Vilazodone) by Application
  1. 5.1 Viibryd (Vilazodone) Market by Application
  2. 5.1.1 Major Depression
  3. 5.1.2 Anxiety
  4. 5.1.3 Others
  5. 5.2 Global Viibryd (Vilazodone) Market Size by Application
  6. 5.2.1 Global Viibryd (Vilazodone) Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Viibryd (Vilazodone) Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Viibryd (Vilazodone) Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Viibryd (Vilazodone) Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Viibryd (Vilazodone) Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Viibryd (Vilazodone) Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Viibryd (Vilazodone) Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Viibryd (Vilazodone) Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Clinical Data, Inc.
  2. 6.1.1 Clinical Data, Inc. Company Information
  3. 6.1.2 Clinical Data, Inc. Business Overview
  4. 6.1.3 Clinical Data, Inc. Viibryd (Vilazodone) Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Clinical Data, Inc. Viibryd (Vilazodone) Product Portfolio
  6. 6.1.5 Clinical Data, Inc. Recent Developments
  7. 6.2 Allergan plc (AbbVie Inc.)
  8. 6.2.1 Allergan plc (AbbVie Inc.) Company Information
  9. 6.2.2 Allergan plc (AbbVie Inc.) Business Overview
  10. 6.2.3 Allergan plc (AbbVie Inc.) Viibryd (Vilazodone) Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Allergan plc (AbbVie Inc.) Viibryd (Vilazodone) Product Portfolio
  12. 6.2.5 Allergan plc (AbbVie Inc.) Recent Developments
  13. 6.3 Actavis Generics (Teva)
  14. 6.3.1 Actavis Generics (Teva) Company Information
  15. 6.3.2 Actavis Generics (Teva) Business Overview
  16. 6.3.3 Actavis Generics (Teva) Viibryd (Vilazodone) Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Actavis Generics (Teva) Viibryd (Vilazodone) Product Portfolio
  18. 6.3.5 Actavis Generics (Teva) Recent Developments
7 North America by Country
  1. 7.1 North America Viibryd (Vilazodone) Sales by Country
  2. 7.1.1 North America Viibryd (Vilazodone) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Viibryd (Vilazodone) Sales by Country (2021-2026)
  4. 7.1.3 North America Viibryd (Vilazodone) Sales Forecast by Country (2027-2032)
  5. 7.2 North America Viibryd (Vilazodone) Market Size by Country
  6. 7.2.1 North America Viibryd (Vilazodone) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Viibryd (Vilazodone) Market Size by Country (2021-2026)
  8. 7.2.3 North America Viibryd (Vilazodone) Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Viibryd (Vilazodone) Sales by Country
  2. 8.1.1 Europe Viibryd (Vilazodone) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Viibryd (Vilazodone) Sales by Country (2021-2026)
  4. 8.1.3 Europe Viibryd (Vilazodone) Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Viibryd (Vilazodone) Market Size by Country
  6. 8.2.1 Europe Viibryd (Vilazodone) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Viibryd (Vilazodone) Market Size by Country (2021-2026)
  8. 8.2.3 Europe Viibryd (Vilazodone) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Viibryd (Vilazodone) Sales by Country
  2. 9.1.1 Asia-Pacific Viibryd (Vilazodone) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Viibryd (Vilazodone) Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Viibryd (Vilazodone) Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Viibryd (Vilazodone) Market Size by Country
  6. 9.2.1 Asia-Pacific Viibryd (Vilazodone) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Viibryd (Vilazodone) Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Viibryd (Vilazodone) Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Viibryd (Vilazodone) Sales by Country
  2. 10.1.1 South America Viibryd (Vilazodone) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Viibryd (Vilazodone) Sales by Country (2021-2026)
  4. 10.1.3 South America Viibryd (Vilazodone) Sales Forecast by Country (2027-2032)
  5. 10.2 South America Viibryd (Vilazodone) Market Size by Country
  6. 10.2.1 South America Viibryd (Vilazodone) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Viibryd (Vilazodone) Market Size by Country (2021-2026)
  8. 10.2.3 South America Viibryd (Vilazodone) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Viibryd (Vilazodone) Sales by Country
  2. 11.1.1 Middle East and Africa Viibryd (Vilazodone) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Viibryd (Vilazodone) Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Viibryd (Vilazodone) Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Viibryd (Vilazodone) Market Size by Country
  6. 11.2.1 Middle East and Africa Viibryd (Vilazodone) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Viibryd (Vilazodone) Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Viibryd (Vilazodone) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Viibryd (Vilazodone) Value Chain Analysis
  2. 12.1.1 Viibryd (Vilazodone) Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Viibryd (Vilazodone) Production Mode & Process
  7. 12.2 Viibryd (Vilazodone) Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Viibryd (Vilazodone) Distributors
  10. 12.2.3 Viibryd (Vilazodone) Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst